Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
47
OGN.V Quote, Financials, Valuation and Earnings
Last price:
$2.59
Seasonality move
:
13.91%
Day range:
$2.57 - $2.60
52-week range:
$1.48 - $2.65
Dividend yield:
0%
P/E ratio:
34.95x
P/S ratio:
22.61x
P/B ratio:
5.79x
Volume:
25.2K
Avg. volume:
25.8K
1-year change:
--
Market cap:
$153.7M
Revenue:
$9.3M
EPS (TTM):
$0.07
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Orogen Royalties, Inc. has 208.88% upside to fair value with a price target of -- per share.
OGN.V vs. S&P 500
-
Over the past 5 trading days, Orogen Royalties, Inc. has overperformed the S&P 500 by 4.05% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Orogen Royalties, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Orogen Royalties, Inc. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Orogen Royalties, Inc. reported revenues of $1.9M.
Earnings Growth
-
Orogen Royalties, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Orogen Royalties, Inc. reported earnings per share of $0.00.
Enterprise value:
133.6M
EV / Invested capital:
--
Price / LTM sales:
22.61x
EV / EBIT:
25.55x
EV / Revenue:
12.61x
PEG ratio (5yr expected):
0.44x
EV / Free cash flow:
64.10x
Price / Operating cash flow:
114.95x
Enterprise value / EBITDA:
25.17x
Gross Profit (TTM):
$9.3M
Return On Assets:
7.64%
Net Income Margin (TTM):
39.1%
Return On Equity:
7.88%
Return On Invested Capital:
7.85%
Operating Margin:
40.83%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $6.9M | $7.6M | $10.6M | $1.4M | $1.9M | |
| Gross Profit | $5.8M | $6.4M | $9.3M | $1.4M | $1.9M | |
| Operating Income | $2.3M | $2.7M | $5.2M | $502.8K | $766.5K | |
| EBITDA | $2.4M | $2.8M | $5.3M | $522.9K | $786.6K | |
| Diluted EPS | $0.05 | $0.04 | $0.07 | -$0.01 | $0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.1M | $11.4M | $18.1M | $24.5M | $23.5M | |
| Total Assets | $11.6M | $52.1M | $60.6M | $66.4M | $28.5M | |
| Current Liabilities | $600.9K | $654.6K | $669.3K | $993.6K | $1.8M | |
| Total Liabilities | $691.1K | $981.5K | $815.6K | $1.1M | $2M | |
| Total Equity | $10.9M | $51.1M | $59.8M | $65.3M | $26.6M | |
| Total Debt | $204.3K | $248K | $197.5K | $149.1K | $205.3K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2M | $3.1M | $2.6M | $914.5K | $405.9K | |
| Cash From Investing | -$2.7M | -$1.7M | -$983.3K | -$81.3K | $2.5M | |
| Cash From Financing | $5.4M | $2.9M | -$7.3M | -$20.1K | -$7.3M | |
| Free Cash Flow | $1.4M | $3.3M | $2.1M | $577.5K | $84.2K | |
OGN.V
Sector
Market Cap
$153.7M
--
Price % of 52-Week High
97.74%
--
Dividend Yield
0%
--
Shareholder Yield
-6.8%
--
1-Year Price Total Return
42.56%
--
Beta (5-Year)
0.309
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.49
200-day SMA
Buy
Level
$1.97
Bollinger Bands (100)
Buy
Level
1.94 - 2.46
Chaikin Money Flow
Sell
Level
-565K
20-day SMA
Buy
Level
$2.43
Relative Strength Index (RSI14)
Buy
Level
64.71
ADX Line
Buy
Level
25.52
Williams %R
Sell
Level
-3.3333
50-day SMA
Buy
Level
$2.33
MACD (12, 26)
Buy
Level
0.05
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
848.9K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (24.8691)
Buy
CA Score
(Annual)
Level (2.0876)
Buy
Beneish M-Score
(Annual)
Level (-2.4376)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-6.4998)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Orogen Royalties, Inc. operates as a royalty and mineral exploration company, which operates a diverse portfolio of precious metal royalties and copper, gold and silver explorations projects. It operates through the following geographical segments: Canada, United States, and Mexico. The company was founded on May 11, 2005 and is headquartered in Vancouver, Canada.
Stock Forecast FAQ
In the current month, OGN.V has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OGN.V average analyst price target in the past 3 months is --.
-
Where Will Orogen Royalties, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Orogen Royalties, Inc. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Orogen Royalties, Inc.?
Analysts are divided on their view about Orogen Royalties, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Orogen Royalties, Inc. is a Sell and believe this share price will drop from its current level to --.
-
What Is Orogen Royalties, Inc.'s Price Target?
The price target for Orogen Royalties, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OGN.V A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Orogen Royalties, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OGN.V?
You can purchase shares of Orogen Royalties, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Orogen Royalties, Inc. shares.
-
What Is The Orogen Royalties, Inc. Share Price Today?
Orogen Royalties, Inc. was last trading at $2.59 per share. This represents the most recent stock quote for Orogen Royalties, Inc.. Yesterday, Orogen Royalties, Inc. closed at $2.59 per share.
-
How To Buy Orogen Royalties, Inc. Stock Online?
In order to purchase Orogen Royalties, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OGN.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OGN.V
Sector
P/E ratio
34.95x
--
PEG ratio
0.44x
--
P/B ratio
5.79x
--
Price / LTM sales
22.61x
--
Growth Metrics
OGN.V
Sector
Revenue growth
31.47%
--
Earnings growth
143.66%
--
Revenue (5-year growth)
30.89%
--
Earnings forecast
--
--
Profitability
OGN.V
Sector
Profitability FY 2024
$5.8M
--
Return on invested capital
7.85%
--
Return on assets
7.64%
--
Return on equity
7.88%
--
Earnings Date
Last Earnings Date
Jan
2
Next Earnings Date
Jan
2
Estimated Next Earnings Date
Apr
3
Balance Sheet
OGN.V
Sector
Total cash
$20.3M
--
Short term investments
$10.2M
--
Total assets
$69.8M
--
Long term debt
$205.3K
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.74% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
